SHARE-BASED COMPENSATION (Tables)
|
6 Months Ended |
May 03, 2026 |
|---|
| SHARE-BASED COMPENSATION [Abstract] |
|
| Share-based Compensation Expenses |
The table below presents information on the Company’s share-based compensation expenses.
| |
|
Three Months Ended
|
|
|
Six Months Ended
|
|
| |
|
May 3,
|
|
|
May 4,
|
|
|
May 3,
|
|
|
May 4,
|
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Expense reported in:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
$
|
894 |
|
|
$
|
785 |
|
|
$
|
1,825 |
|
|
$
|
1,562 |
|
|
Selling, general, and administrative
|
|
|
2,657 |
|
|
|
2,288 |
|
|
|
5,140 |
|
|
|
4,556 |
|
|
Research and development
|
|
|
174 |
|
|
|
302 |
|
|
|
(389 |
)
|
|
|
592 |
|
|
Total expense incurred
|
|
$
|
3,725 |
|
|
$
|
3,375 |
|
|
$
|
6,576 |
|
|
$
|
6,710 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expense by award type:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock awards
|
|
$
|
2,197 |
|
|
$
|
2,809 |
|
|
$
|
4,240 |
|
|
$
|
6,086 |
|
|
Restricted stock units
|
|
|
1,490 |
|
|
|
509 |
|
|
|
2,259 |
|
|
|
509 |
|
|
Employee stock purchase plan
|
|
|
38 |
|
|
|
57 |
|
|
|
77 |
|
|
|
115 |
|
|
Total expense incurred
|
|
$
|
3,725 |
|
|
$
|
3,375 |
|
|
$
|
6,576 |
|
|
$
|
6,710 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax benefits on share-based compensation
|
|
$
|
780 |
|
|
$
|
406 |
|
|
$
|
1,362 |
|
|
$
|
852 |
|
|
| Restricted Stock Awards Activity |
The table below presents information on the Company’s restricted stock awards. | | | Three Months Ended | | | Six Months Ended | | | | | May 3, | | | May 4, | | | May 3, | | | May 4, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Number of shares granted in period | | | - | | | | 237,738 | | | | - | | | | 583,238 | | | Weighted-average grant-date fair value of awards (in dollars per share) | | $ | - | | | $ | 21.28 | | | $ | - | | | $ | 23.42 | | | Compensation cost not yet recognized | | $ | 15,225 | | | $ | 27,028 | | | $ | 15,225 | | | $ | 27,028 | | | Weighted-average amortization period for cost not yet recognized (in years) | | | 2.2 | | | | 3.0 | | | | 2.2 | | | | 3.0 | | | Restricted shares outstanding at balance sheet date | | | 809,986 | | | | 1,439,672 | | | | 809,986 | | | | 1,439,672 | |
|
| Restricted Stock Units Activity |
The table below presents information on the Company’s restricted stock unit awards. | | | Three Months Ended | | | Six Months Ended | | | | | May 3, | | | May 4, | | | May 3, | | | May 4, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Number of units granted in period | | | 80,529 | | | | 52,836 | | | | 589,601 | | | | 52,836 | | | Weighted-average grant-date fair value of awards (in dollars per share) | | $ | 41.09 | | | $ | 22.52 | | | $ | 33.99 | | | $ | 22.52 | | | Compensation cost not yet recognized | | $ | 16,992 | | | $ | 681 | | | $ | 16,992 | | | $ | 681 | | | Weighted-average amortization period for cost not yet recognized (in years) | | | 3.6 | | | | 0.8 | | | | 3.6 | | | | 0.8 | | | Restricted stock units outstanding at balance sheet date | | | 676,982 | | | | 33,966 | | | | 676,982 | | | | 33,966 | |
|
| Stock Options Activity |
The table below presents information on the Company’s stock options.
| |
|
Three Months Ended
|
|
|
Six Months Ended
|
|
| |
|
May 3,
|
|
|
May 4,
|
|
|
May 3,
|
|
|
May 4,
|
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Number of options granted in period
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
Cash received from options exercised
|
|
$
|
359 |
|
|
$
|
26 |
|
|
$
|
992 |
|
|
$
|
1,298 |
|
|
Compensation cost not yet recognized
|
|
$
|
- |
|
|
$
|
- |
|
|
$
|
- |
|
|
$
|
- |
|
|
Weighted-average amortization period for cost not yet recognized (in years)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
| Outstanding and Exercisable Option |
Information regarding outstanding and exercisable option awards as of May 3, 2026, is presented below.
| | |
|
|
|
|
| Weighted |
|
|
|
| | | |
|
|
| Weighted |
| Average |
|
|
|
| | | |
|
|
| Average |
| Remaining |
|
| Aggregate |
| | | |
|
|
| Exercise |
| Contractual |
|
| Intrinsic | | | Options | | | | | Price |
| Life (in years) |
|
| Value | | | Outstanding and exercisable at May 3, 2026 |
|
| 19,250 |
|
| $ | 9.51 |
|
| 1.79 |
|
| $ | 783 | |
|